Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Alimentiv Inc.

Home Clinical Trial Sponsors and OrganizationsAlimentiv Inc.

Alimentiv Inc.

200-100 Dundas St, London, Ontario, Canada

Also known as:

alimentiv health trust

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

18

6 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 4

6

33.3%

Phase 1

4

22.2%

Not Applicable

1

5.6%

Phase 2

1

5.6%

Trial Status Distribution

Active, not recruiting

6

33.3%

Completed

3

16.7%

Recruiting

6

33.3%

Suspended

1

5.6%

Terminated

2

11.1%

Clinical Trials

Trials sponsored by this organization (18)

Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to CD

Apr 202660 participants

A Prospective Randomised Study of Treatment Selection Based on Epigenetic Markers Versus Standard of Care Treatment Selection in Adults With CROHN's Disease

Feb 2025378 participants

VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease

Aug 2024304 participants

Development of a Novel Endoscopic Index and Patient-reported Outcome Measure for Clinical Trials in Participants With Permanent Ileostomy

Jun 202450 participants

VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With Crohn's Disease: A Prospective Observational Study

Active, not recruiting

Mar 2024300 participants

VECTORS – A study to evaluate transmural healing as a treatment target in Crohn’s disease

Mar 2024266 participants

Assessment of Patients With Acute Pouchitis Treated With Antibiotics

Dec 202143 participants

Identification of Biomarkers of Janus Kinase Inhibitor Therapy in Patients With Ulcerative Colitis

Aug 20203 participants

Page 1 of 3

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials18
Approvals
News

Back to Organizations